Thromb Haemost 1992; 67(06): 726
DOI: 10.1055/s-0038-1648532
Letters to the Editor
Schattauer GmbH Stuttgart

Deterioration of Reference Material for Human Thromboplastin

A M H P van den Besselaar
Thrombosis and Haemostasis Research Unit, Department of Haematology, Leiden University Hospital, Building 1, C2-R, P. O. Box 9600, 2300 RC Leiden, The Netherlands
,
J Meeuwisse-Braun
Thrombosis and Haemostasis Research Unit, Department of Haematology, Leiden University Hospital, Building 1, C2-R, P. O. Box 9600, 2300 RC Leiden, The Netherlands
,
H Schaefer-Van Mansfeld
Thrombosis and Haemostasis Research Unit, Department of Haematology, Leiden University Hospital, Building 1, C2-R, P. O. Box 9600, 2300 RC Leiden, The Netherlands
› Author Affiliations
Further Information

Publication History

Received 23 December 1991

Accepted 10 January 1992

Publication Date:
03 July 2018 (online)

 
  • References

  • 1 WHO Expert Committee on Biological standardization 33rd Report. WHO Techn Rep Ser 1983; 687: 81-105
  • 2 Lewis SM. Thromboplastin and oral anticoagulant control. Br J Haematol 1987; 66: 1-4
  • 3 Van den Besselaar AMHP, Bertina RM. Multi-center calibration of the second reference material for thromboplastin, rabbit, plain, coded CRM149R. Thromb Haemostas 1991; 65: 263-267
  • 4 Van den Besselaar AMHP, Hermans J, Beeser H, Loeliger EA. Longterm stability of international reference preparations for thromboplastins. Br J Haematol 1988; 68: 321-328
  • 5 Stevenson KJ, Slater PJ, Poller L. The British Comparative Thromboplastin: the relationship between lipid class composition and procoagulant activity. Br J Haematol 1980; 44: 495-501
  • 6 Thomson JM, Darby KV, Poller L. Calibration of BCT/441, the ICSH reference preparation for thromboplastin. Thromb Haemostas 1986; 55: 379-382
  • 7 WHO Expert Committee on Biological Standardization. WHO Techn Rep Ser 1990; 800: 190